首页> 外文OA文献 >Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer

【2h】

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer

机译：雄激素受体基因畸变在循环无细胞DNA中的临床用途作为一种用于治疗抗阉割前列腺癌的生物标志物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Takayuki Sumiyoshi; Kei Mizuno; Toshinari Yamasaki; Yu Miyazaki; Yuki Makino; Kosuke Okasho; Xin Li; Noriaki Utsunomiya; Takayuki Goto; Takashi Kobayashi; Naoki Terada; Takahiro Inoue; Tomomi Kamba; Akihiro Fujimoto; Osamu Ogawa; Shusuke Akamatsu;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer [J] . Takayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, Scientific reports. . 2019,第1期

机译：循环中无细胞DNA中雄激素受体基因畸变作为治疗去势抵抗性前列腺癌的生物标志物的临床应用
2. Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer [J] . Azad Arun A., Volik Stanislav V., Wyatt Alexander W., Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第10期

机译：循环无细胞DNA中的雄激素受体基因畸变：去势抵抗性前列腺癌的治疗抗性的生物标志物。
3. Re: Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer Editorial Comment [J] . Taneja Samir S. The Journal of Urology . 2015,第3期

机译：Re：在循环无细胞DNA中的雄激素受体基因畸变：抗阉割前列腺癌中的治疗性抗性的生物标志物编辑评论
4. Circulating Cell-Free DNA-Based qMSP Demonstrates That Sydecan2 Methylation as a Promising Epigenetic Biomarker for Early Detection of Patients with Precancerous and Cancerous Colorectal Lesions [C] . Sungwhan An, TaeJeong Oh, Dongjun Jeong, Molecular Medicine TRI-CON. . 2014

机译：循环无细胞的DNA基QMSP证明了Sydecan2甲基化作为有望的表观遗传生物标志物，用于早期检测患癌前和癌细胞病患者的患者
5. Reprogramming androgen receptor and lysine-specific demethylase 1 transcriptome in castration-resistant prostate cancer [D] . Rizvi, Abbas Ali. 2015

机译：重编程雄激素受体和赖氨酸特异性脱甲基酶1转录组在去势抵抗性前列腺癌中
6. Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer [O] . Takayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, -1

机译：循环中无细胞DNA中雄激素受体基因异常作为治疗去势抵抗性前列腺癌的生物标志物的临床应用
7. Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer [O] . Arun A. Azad, Stanislav V. Volik, Alexander W. Wyatt, 2015

机译：在循环无细胞DNA中的雄激素受体基因像素：抗阉割前列腺癌中治疗性的生物标志物

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer

著录项

相似文献

相关主题

期刊订阅